Effect of Donepezil on Speech Recognition in Cochlear Implant Users

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions

Bilateral Sensorineural Hearing Loss

Interventions

DRUG

Donepezil

acetylcholinesterase inhibitor

DRUG

Placebo

placebo

Trial Locations (1)

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER